secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cyclerion Therapeutics, Inc. (CYCN)
CIK:        0001755237
Form:       8-K
Filed at:   2022-07-26T23:59:59+00:00
Accession:  0001140361-22-026908
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclerion appoints Steven E. Hyman to board; former NIMH director and neuroscience leader
--------------------------------------------------------------------------------

- Steven Hyman appointed to Board effective July 25, 2022, following Board expansion from 8 to 9 members.
- Hyman serves on Science Committee; is director of Stanley Center for Psychiatric Research at Broad Institute.
- Previously served as director of NIMH (1996-2001) and provost of Harvard University (2001-2011).
- Will help shape clinical strategy for lead molecule CY6463 and expand external collaborations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1755237/000114036122026908/0001140361-22-026908-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1755237/000114036122026908/brhc10039916_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-22-026908

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer